SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-19-006387
Filing Date
2019-05-03
Accepted
2019-05-03 17:06:26
Documents
6
Effectiveness Date
2019-05-03

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 237055
2 ex4-2.htm EX-4.2 63191
3 ex5-1.htm EX-5.1 14605
4 ex23-1.htm EX-23.1 4524
5 logo_001.jpg GRAPHIC 13799
6 img_001.jpg GRAPHIC 3293
  Complete submission text file 0001493152-19-006387.txt   344439
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-231219 | Film No.: 19797139
SIC: 2834 Pharmaceutical Preparations